Diabetes modifies the association of prehypertension with cardiovascular disease and all‐cause mortality-Reference-Cited by-同舟云学术

Diabetes modifies the association of prehypertension with cardiovascular disease and all‐cause mortality

Published:2021-04-04 Issue:6 Volume:23 Page:1221-1228
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Ren Yanlong¹,Zuo Yingting²³^ORCID,Wang Anxin⁴⁵,Chen Shuohua⁶,Tian Xue²³,Li Haibin⁷,He Yan²³,Wu Shouling⁶,Ma Changsheng¹⁸

Affiliation:

1. Department of Cardiology Beijing Anzhen Hospital Capital Medical University Beijing China

2. Department of Epidemiology and Health Statistics School of Public Health Capital Medical University Beijing China

3. Beijing Municipal Key Laboratory of Clinical Epidemiology Beijing China

4. China National Clinical Research Center for Neurological Diseases Beijing Tiantan Hospital Capital Medical University Beijing China

5. Department of Neurology Beijing Tiantan Hospital Capital Medical University Beijing China

6. Department of Cardiology Kailuan Hospital North China University of Science and Technology Tangshan China

7. Department of Epidemiology Beijing Chaoyang Hospital Capital Medical University Beijing China

8. National Clinical Research Center for Cardiovascular Diseases Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.14246

Reference34 articles.

1. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report

2. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension‐A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension;J Geriatr Cardiol,2019

3. Prehypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study

4. Prehypertension and Cardiovascular Disease Risk in the Women’s Health Initiative

5. Impact of lower range of prehypertension on cardiovascular events in a general population

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and rationale for a randomized, open-label, parallel clinical trial evaluating major adverse cardiovascular events (pharmacological treatment versus diet control) in patients with high-normal blood pressure: the PRINT-TAHA9 trial;Trials;2024-08-26

2. Design and Rationale for a Randomized, Open-Label, Parallel Clinical Trial Evaluating Major Cardiovascular Events (Pharmacological Treatment Versus Diet Control) in Patients with High-Normal Blood Pressure: The PRINT-TAHA9 Trial;2024-06-12

3. Changes in baPWV and the risk of clinical outcomes: a cohort study of Chinese community-based population;Journal of Human Hypertension;2024-02-27

4. Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular mortality between normotensive and hypertensive individuals;Journal of Hypertension;2024-01-24

5. Hypertension and Pre-Hypertension in Middle East and North Africa (MENA): A Meta-Analysis of Prevalence, Awareness, Treatment, and Control;Current Problems in Cardiology;2021-11